The board of directors of CSPC Pharmaceutical Group Limited announced that with effect from 21 May 2019, Mr. PAN Weidong an executive director of the company, ceased as Vice-Chairman of the company and remains as executive director; Mr. WANG Zhenguo an executive director of the company, ceased as Vice-Chairman and Rotating Chief Executive Officer of the company and remains as executive director; and Mr. Zhang Cuilong an executive director of the Company, has been appointed as Vice-Chairman and Rotating Chief Executive Officer of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.03 HKD | +0.67% |
|
+0.17% | -16.94% |
12/07 | CSPC Pharmaceutical Group's Respiratory Vaccine Gets NMPA's Nod for Clinical Trials | MT |
12/07 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.94% | 905.97Cr | |
+55.35% | 85TCr | |
+31.64% | 63TCr | |
-0.10% | 36TCr | |
+15.47% | 32TCr | |
+13.10% | 30TCr | |
+15.51% | 24TCr | |
+16.72% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- 1093 Stock
- News CSPC Pharmaceutical Group Ltd.
- CSPC Pharmaceutical Group Limited Announces Management Changes